Investigation of the cellular dynamics of antagonist-mediated endocytosis of group I metabotropic glutamate receptors
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
IISERM
Abstract
G-protein coupled receptors bind to a variety of ligand molecules. An agonist is a ligand
that when binds to the receptor leads to its activation and consequently a biological
cascade in the cell. An antagonist however, is known to pharmacologically block the
action of the agonist by binding to the receptor and preventing activation of the receptor
by blocking receptor-agonist interaction and downstream signaling. Subsequent to the
activation of the second messenger pathways, many G-protein coupled receptors
(GPCRs) are known to get desensitized and get internalized. Till date, antagonists, which
are viewed as pharmacological blockers only, were not known to promote sequestration
of receptors upon binding. However, some studies have reported antagonist-induced
desensitization of a few GPCRs and uncoupling of the receptor from the G-protein
involved. Group I metabotropic glutamate receptors (mGluRs) play crucial roles,
especially in inducing different forms of synaptic plasticity which are responsible for
learning and memory formation. Group I mGluRs activate the phospholipase C pathway
by coupling to the G αq/11 pathway.
In this study I determined whether the lesser known concept antagonists-mediated
endocytosis is applicable to group I mGluRs in primary hippocampal neurons. It has been
reported earlier that group I mGluRs show maximum internalization 30 mins post agonist
stimulation. The objective of this study was to check if antagonists induce the
internalization of mGluR1 and mGluR5, the two subtypes of the group I mGluRs.
Further, I was interested to investigate the kinetics and the fate of the receptor subsequent
to the internalization. Our results add to the understanding of the little known concept of
antagonist-mediated internalization which is perhaps crucial because these antagonists
are widely used in therapeutics. The detailed cellular mechanisms need to be investigated
in future